Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Antigen Targeted T cell therapy for Relapsed/Refractory B cell Lymphomas'. The following are the o... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779174) titled 'Prevalence and Measurement of Delayed Gastric Emptying in Patients Receiving Extracorporeal... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779460) titled 'A Study Comparing Effectiveness of Kesimpta(R) (Ofatumumab) Versus Ocrevus(R) (Ocrelizumab)... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A multicenter open-label extension study to evaluate long-term safety and efficacy of QCZ484 in hy... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... Read More